Work

Supplemental Tables from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Tables

DOI: 10.1158/1078-0432.22465980.v1

Authors: Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi, Lianne Vriend, Simon Yue, Tetsuro Sasada, Wanyong Zeng, Yo Mizukami, Justice Clark, David Nemer, Kenneth LeClair, Christine Canning, Heather Daley, Glenn Dranoff, Anita Giobbie-Hurder, F. Stephen Hodi, Jerome Ritz, Steven P. Balk

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361928071

Cites:

Cited by:

Related to: 10